[ad_1]
Text size
Warren Buffett’s Berkshire Hathaway
recently made some significant changes to their portfolio, in addition to buying
Verizon Communications
and
Chevron,
and sell
Apple
Stock.
In the fourth quarter, Berkshire (ticker:
BRK.B
) added to positions in
Merck
(MRK),
Bristol-Myers Squibb
(BMY), and
AbbVie
(ABBV), and left an investment in
Pfizer
(PFE). Buffett’s business also continued to cut
Wells fargo
(WFC) and sold all of its
PNC Financial Services
(PNC). Elsewhere, Berkshire bought more
Kroger
(KR) and reduced its investment in
General Motors
(GM).
Buffett’s company disclosed stock transactions, among other things, in a form filed with the Securities and Exchange Commission.
Berkshire Hathaway did not immediately respond to a request for comment on the investment changes.
The company increased its investments in Merck, Bristol-Myers and AbbVie by 28.1% to 28.7 million shares, by 11.2% to 33.3 million shares and by 20% to 25.5 million actions, respectively. Berkshire Hathaway sold all of the 3.7 million Pfizer shares in the fourth quarter it held at the end of the third.
Berkshire Hathaway reduced its stake in Wells Fargo from 59% to 52.4 million shares and sold the 1.9 million PNC shares it held.
Buffett’s company increased its stake in grocer Kroger by 34.3%, ending 2020 with 33.5 million shares. Berkshire sliced its stake in GM from 9.4% to 72.5 million shares.
Inside Scoop is a regular feature of Barron that covers the stock trading of corporate executives and board members – called insiders – as well as big shareholders, politicians and other important people. Due to their insider status, these investors are required to disclose stock transactions with the Securities and Exchange Commission or other regulatory groups..
Write to Ed Lin at [email protected] and follow @BarronsEdLin.
[ad_2]
Source link